Sublingual Misoprostol and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section

• Status: Unknown status
• Trial end date: 2021-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

Purpose to evaluate the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women with twin pregnancy undergoing an elective cesarean section.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Misoprostol; Tranexamic Acid

Criteria

Inclusion Criteria:

• women with a multiple term pregnancy undergoing elective cesarean section

Exclusion Criteria:

• single gestation

• placenta praevia and placental abruption

• undergoing cesarean section with general anesthesia

• women undergoing cesarean section at less than 37 weeks of gestation

• with a severe medical disorder

• allergy to tranexamic acid or misoprostol